OR WAIT null SECS
June 01, 2018
Catalent’s GPEx technology was used to develop antibody for anti-methamphetamine clinical study.
Cambrex invests $5 million in new laboratory expansion at its Karlskoga, Sweden facility.
May 16, 2018
Valerius Biopharma will use Catalent’s GPEx technology to produce cell lines for biosimilar drugs.
April 24, 2018
Porton will use biocatalyst technologies from Codexis to accelerate API development for clients.
April 20, 2018
The contract renewal allows AMRI to continue to provide medicinal chemistry and ADME services for advancing drug discovery programs in neurotherapeutics.
April 06, 2018
Anthony Qu, PhD, vice president of Scientific Affairs at Halo Pharma, will give a presentation on fixed-dose combination products, drug products containing multiple active ingredients, as an effective approach for simplified dosing at CPhI North America on Wednesday, April 25, 2018 in Philadelphia, PA.
April 05, 2018
The contract development and manufacturing organization announced the addition of a new building complex that will house its headquarters in Bothell, WA.
March 19, 2018
Hovione plans to continue to expand its sites in Portugal and Ireland for chemical synthesis, spray drying, and laboratory analysis.
February 13, 2018
A $800-million acquisition of MPI Research expands Charles River's offerings for early-stage contract research.
February 09, 2018
The companies will partner to further immuno-oncology research using humanized mice.